文献速递膀胱癌与上尿路尿路上皮癌

WHO 1973分级系统是T1非肌层浸润性膀胱癌的重要预后因素

The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
PubMed 文献 · BJU Int · 2018-04-27

该研究比较WHO 1973与2004分级系统在601例原发性T1膀胱癌中的预后价值,患者均接受卡介苗保守治疗。中位随访5.9年,WHO1973 Grade 3与无进展生存期和癌症特异性生存期显著负相关,而WHO2004分级无预后价值。多因素分析中WHO1973分级是进展的唯一预后因素。

要点

  • WHO1973分级在T1膀胱癌中具有强预后价值,WHO2004分级无预后价值。
  • WHO1973 Grade 3与更差的无进展生存期和癌症特异性生存期独立相关。
  • 非肌层浸润性膀胱癌指南中WHO1973分级不能被WHO2004分级替代。

核心结论

  • WHO1973分级系统在T1膀胱癌中具有强预后价值,优于WHO2004系统,提示指南中不能以WHO2004分级替代WHO1973分级。

研究设计与样本

  • 回顾性队列研究,3名泌尿病理学家重新修订601例原发性T1膀胱癌切片,患者来自4家医院并初始接受卡介苗保守治疗。

主要发现

  • 中位随访5.9年,148例进展,94例死于膀胱癌。
  • WHO1973 Grade 3与无进展生存期负相关(HR 2.1)且与癌症特异性生存期负相关(HR 3.4),WHO2004分级无预后价值。
  • 多因素分析中WHO1973分级是进展的唯一预后因素(HR 2.0)。
  • Grade 3肿瘤(HR 3.0)、年龄较大(HR 1.03)和肿瘤大小>3 cm(HR 1.8)均与更差的癌症特异性生存期独立相关。

关键数值与推荐

  • WHO1973分级:无Grade 1肿瘤,Grade 2为188例(31%),Grade 3为413例(69%)。
  • WHO2004分级:低级别47例(8%),高级别554例(92%)。

临床怎么用

  • 在T1非肌层浸润性膀胱癌的临床预后评估和指南制定中,应重视WHO1973分级系统,不应仅依赖WHO2004分级。

局限性

  • 本研究为回顾性设计,患者均接受卡介苗保守治疗,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 classification systems for grade in T1 bladder cancer (T1-BC), as both are currently recommended in international guidelines. PATIENTS AND METHODS: Three uro-pathologists re-revised slides of 601 primary (first diagnosis) T1-BCs, initially managed conservatively (bacille Calmette-Guérin) in four hospitals. Grade was defined according to WHO1973 (Grade 1-3) and WHO2004 (low-grade [LG] and high-grade [HG]). This resulted in a lack of Grade 1 tumours, 188 (31%) Grade 2, and 413 (69%) Grade 3 tumours. There were 47 LG (8%) vs 554 (92%) HG tumours. We determined the prognostic value for progression-free survival (PFS) and cancer-specific survival (CSS) in Cox-regression models and corrected for age, sex, multiplicity, size and concomitant carcinoma in situ. RESULTS: At a median follow-up of 5.9 years, 148 patients showed progression and 94 died from BC. The WHO1973 Grade 3 was negatively associated with PFS (hazard ratio [HR] 2.1) and CSS (HR 3.4), whilst WHO2004 grade was not prognostic. On multivariable analysis, WHO1973 grade was the only prognostic factor for progression (HR 2.0). Grade 3 tumours (HR 3.0), older age (HR 1.03) and tumour size >3 cm (HR 1.8) were all independently associated with worse CSS. CONCLUSION: The WHO1973 classification system for grade has strong prognostic value in T1-BC, compared to the WHO2004 system. Our present results suggest that WHO1973 grade cannot be replaced by the WHO2004 classification in non-muscle-invasive BC guidelines.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. van de Putte EEF, Bosschieter J, van der Kwast TH, et al. The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer. BJU Int. 2018. PMID: 29637669. doi:10.1111/bju.14238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。